CMS NCD drops clinical trial requirement for FDG PET scans for solid tumors
May 6th, 2014 - Scott KraftCategories: Billing National Coverage Determinations (NCD)
Patients no longer need to be in a CMS-approved clinical trial for physician practices to get paid for doing as many as four FDG PET scans for solid tumors – one for an initial treatment strategy and three to guide subsequent treatments, according to CMS transmittal 8739 to its Medicare Claims Processing Manual.
In some instances, even more than four scans can be done when they are medically necessary, in line with the Medicare Administrative Contractors (MACs) payment policy for exceptions to the frequency limit and billed using the KX modifier (qualify for an exception under the automatic exception process).
The frequency limit is per cancer diagnosis, so a patient who has multiple cancers can get up to four scans when medically necessary for the treatment of each individual diagnosis. This policy change is a national coverage determination (NCD), meaning it applies to all MACs.
The transmittal took effect April 18, but CMS has backdated the change to June 11, 2013. Any claims done on or after June 11 can be resubmitted to the MAC for reconsideration, but won’t automatically be reprocessed.
The PET scan CPT® codes addressed under the NCD are 78608, 78811, 78812, 78813, 78814, 78815 and 78816.
Under the new policy, when billing the initial PET scan as part of establishing a treatment strategy for the cancer, you would append modifier PI. Each of the three additional PET scans allowed for subsequent treatment strategy would be billed with the modifier PS.
Whether or not a PET scan is billed with modifier PI doesn’t have any bearing on the three PET scan limit for each cancer diagnosis billed with the PS modifier. The fourth PET scan billed with PS will automatically be denied, unless the KX modifier is attached as noted above.
Modifiers Q0 and Q1 for investigational research or clinical trials are no longer required on claims with dates of service on or after June 11, nor is diagnosis code V70.7 for examination of patient in a clinical trial.
When these services are rejected because the PS modifier is not used you may see claim adjustment reason code 4 (the procedure code is inconsistent with the modifier used or a required modifier is missing), remittance advice remark code MA-130 (Your claim contains incomplete and/or invalid information, and no appeal rights are afforded because the claim is unprocessable. Submit a new claim with the correct/complete information).
For a list of the diagnosis codes affected by the NCD change, see page 14 of the attached document.
###
Questions, comments?
If you have questions or comments about this article please contact us. Comments that provide additional related information may be added here by our Editors.
Latest articles: (any category)
Artificial Intelligence in Healthcare - A Medical Coder's PerspectiveDecember 26th, 2023 - Aimee Wilcox
We constantly hear how AI is creeping into every aspect of healthcare but what does that mean for medical coders and how can we better understand the language used in the codeset? Will AI take my place or will I learn with it and become an integral part of the process that uses AI to enhance my abilities?
Specialization: Your Advantage as a Medical Coding ContractorDecember 22nd, 2023 - Find-A-Code
Medical coding contractors offer a valuable service to healthcare providers who would rather outsource coding and billing rather than handling things in-house. Some contractors are better than others, but there is one thing they all have in common: the need to present some sort of value proposition in order to land new clients. As a contractor, your value proposition is the advantage you offer. And that advantage is specialization.
ICD-10-CM Coding of Chronic Obstructive Pulmonary Disease (COPD)December 19th, 2023 - Aimee Wilcox
Chronic respiratory disease is on the top 10 chronic disease list published by the National Institutes of Health (NIH). Although it is a chronic condition, it may be stable for some time and then suddenly become exacerbated and even impacted by another acute respiratory illness, such as bronchitis, RSV, or COVID-19. Understanding the nuances associated with the condition and how to properly assign ICD-10-CM codes is beneficial.
Changes to COVID-19 Vaccines Strike AgainDecember 12th, 2023 - Aimee Wilcox
According to the FDA, CDC, and other alphabet soup entities, the old COVID-19 vaccines are no longer able to treat the variants experienced today so new vaccines have been given the emergency use authorization to take the place of the old vaccines. No sooner was the updated 2024 CPT codebook published when 50 of the codes in it were deleted, some of which were being newly added for 2024.
Updated ICD-10-CM Codes for AppendicitisNovember 14th, 2023 - Aimee Wilcox
With approximately 250,000 cases of acute appendicitis diagnosed annually in the United States, coding updates were made to ensure high-specificity coding could be achieved when reporting these diagnoses. While appendicitis almost equally affects both men and women, the type of appendicitis varies, as dose the risk of infection, sepsis, and perforation.
COVID Vaccine Coding Changes as of November 1, 2023October 26th, 2023 - Wyn Staheli
COVID vaccine changes due to the end of the PHE as of November 1, 2023 are addressed in this article.
Medicare Guidance Changes for E/M ServicesOctober 11th, 2023 - Wyn Staheli
2023 brought quite a few changes to Evaluation and management (E/M) services. The significant revisions as noted in the CPT codebook were welcome changes to bring other E/M services more in line with the changes that took place with Office or Other Outpatient Services a few years ago. As part of CMS’ Medicare Learning Network, the “Evaluation and Management Services Guide” publication was finally updated as of August 2023 to include the changes that took place in 2023. If you take a look at the new publication (see references below),....
